Clinical Trial Update: Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating GM-CT-01 in combination with 5-FU for bile duct cancer and gallbladder cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer of the Bile Duct
• Gallbladder Cancer

Drugs mentioned

• 5-FU (5-fluorouracil)
• GM-CT-01 (GM-CT-01)

Snippet

Sponsor: Galectin Therapeutics Inc. | Conditions: Cancer of the Bile Duct, Gallbladder Cancer | Phase 2 | Status: WITHDRAWN